Sterile generic drug manufacturer with 24/7 respiratory and injectable operations
Nephron manufactures sterile generics across respiratory, injectables, and ophthalmics with continuous operations supported by industrial automation (Allen-Bradley, Siemens, FactoryTalk). Heavy hiring in manufacturing and ops—21 of 37 active roles—paired with active projects in validation, equipment qualification, and batch-record process improvement, indicates capacity expansion and tightening of quality systems. Pain points cluster around FDA compliance, QA friction, and deviation investigation turnaround, typical pressure points for cGMP manufacturers scaling throughput.
Nephron Pharmaceuticals is a sterile drug manufacturer based in West Columbia, South Carolina, operating continuously since 1937. The company specializes in generic respiratory medications (asthma, COPD) and contract manufacturing of sterile products across respiratory, injectable, and ophthalmic categories, serving hospitals, pharmacies, long-term care, home care, and mail-order channels. Operations are built on industrial control systems (Siemens, Allen-Bradley PLC environments) and laboratory analytics (HPLC, FT-IR), with 501–1,000 employees managing 24/7/365 manufacturing cycles.
Nephron manufactures sterile generic medications in respiratory, injectable, and ophthalmic categories, including 503B outsourcing and contract manufacturing. Primary focus is generics for asthma and COPD, distributed to hospitals, pharmacies, long-term care, and mail-order channels.
Manufacturing: Allen-Bradley, Siemens, FactoryTalk View/Historian/AssetCentre, RSLogix, Compact Logix, Metasys. Lab: HPLC, FT-IR. Enterprise: GCP, Outlook, Excel, SharePoint, LabVantage for lab data. No recent tech replacements logged.
Other companies in the same industry, closest in size